Valuation: Astal Laboratories Limited

Market Cap 2.76B 28.49M 25.06M 23.28M 21.41M 40.15M 40.87M 278M 109M 1.35B 107M 105M 4.67B P/E 2024
26.3x
P/E 2025 9.45x
Enterprise Value 2.87B 29.68M 26.11M 24.25M 22.31M 41.83M 42.58M 290M 113M 1.4B 111M 109M 4.86B EV / Sales 2024
1.45x
EV / Sales 2025 1.36x
Free-Float
41.06%
Yield 2024 *
-
Yield 2025 -
1 day+1.81%
1 week-1.40%
Current month-9.58%
1 month+3.81%
3 months+26.54%
6 months-0.73%
Current year-7.38%
1 week 77.5
Extreme 77.5
83.89
1 month 77.5
Extreme 77.5
91.3
Current year 60.45
Extreme 60.45
91.9
1 year 60.45
Extreme 60.45
103.2
3 years 24
Extreme 24
131.7
5 years 5.41
Extreme 5.41
131.7
10 years 5.41
Extreme 5.41
131.7
Manager TitleAgeSince
Director of Finance/CFO 51 2023-07-14
Compliance Officer 32 2023-04-18
Director TitleAgeSince
Director/Board Member 55 2023-08-17
Director/Board Member 62 -
Director/Board Member - 2022-09-07
Change 5-day change 1-year change 3-year change Capi.($)
+1.81%-1.40%-17.04%+209.86% 35.77M
+1.97%+1.43%+48.44%+156.66% 1,037B
+1.42%+3.72%+53.32%+52.34% 615B
+1.43%+0.99%+34.83%+78.74% 448B
+5.14%+5.40%+33.75%+27.28% 326B
+1.85%+3.57%+37.09%+39.87% 293B
-0.11%+0.48%+18.87%+17.81% 264B
+0.25%-4.62%-27.66%-42.25% 216B
+1.49%-0.02%+20.14%+58.21% 198B
+0.40%-3.99%+15.23%+62.28% 162B
Average +1.56%-0.36%+21.70%+66.08% 355.75B
Weighted average by Cap. +1.73%+1.12%+35.40%+75.24%

Financials

2024 2025
Net sales 237M 2.44M 2.15M 2M 1.84M 3.44M 3.5M 23.87M 9.31M 115M 9.17M 8.97M 400M 637M 6.57M 5.78M 5.37M 4.94M 9.26M 9.43M 64.22M 25.05M 310M 24.68M 24.14M 1.08B
Net income 7.85M 81.03K 71.27K 66.2K 60.89K 114K 116K 792K 309K 3.83M 304K 298K 13.28M 89.25M 922K 811K 753K 693K 1.3M 1.32M 9M 3.51M 43.53M 3.46M 3.39M 151M
Net Debt -57.64M -595K -524K -486K -447K -839K -854K -5.82M -2.27M -28.12M -2.23M -2.19M -97.54M 115M 1.19M 1.05M 973K 895K 1.68M 1.71M 11.64M 4.54M 56.28M 4.47M 4.38M 195M
Logo Astal Laboratories Limited
Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.
Employees
-
Date Price Change Volume
26-07-23 ₹80.44 +1.81% 9,889
26-07-22 ₹79.01 -2.79% 9,475
26-07-21 ₹81.28 -0.67% 6,819
26-07-20 ₹81.83 +3.54% 10,244
26-07-17 ₹79.03 -3.13% 9,304
  1. Stock Market
  2. Stocks
  3. MACINTR Stock